$LPATH INC(LPTN)$ 好消息Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD (Nexus)
This study has been completed.
Sponsor:
Lpath, Inc.
Information provided by (Responsible Party):
Lpath, Inc.
ClinicalTrials.gov Identifier:
NCT01414153
First received: August 9, 2011
Last updated: September 15, 2015
Last verified: September 2015
History of Changes
新药被批准l.